We can expect the following in the coming weeks:
- Race is exploring low-cost collaborative preclinical studies focused on understanding the
molecular mechanism of action of Bisantrene’s heart safety profile. Advanced discussions are
underway with a leading Australian team specialising in anthracycline cardiotoxicity research.
Race expects to update the market on the outcome of these discussions in early Q2 CY 2021.
- Race has reached in principle agreement with Prof Nagler of the Chiam Sheba Medical Center (ranked 10 in the world) to undertake an open label Phase I/II combination clinical trial of Bisantrene in r/r AML patients. Trial contract details are current being finalised and Race expects to sign in early Q2 CY 2021.
- Forums
- ASX - By Stock
- RAC - Charts & Price Action
We can expect the following in the coming weeks:- Race is...
-
-
- There are more pages in this discussion • 16,139 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAC (ASX) to my watchlist
|
|||||
Last
$1.73 |
Change
0.030(1.76%) |
Mkt cap ! $296.3M |
Open | High | Low | Value | Volume |
$1.74 | $1.75 | $1.70 | $101.5K | 58.84K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 955 | $1.71 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.73 | 1574 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 955 | 1.705 |
2 | 10402 | 1.700 |
1 | 449 | 1.695 |
2 | 15500 | 1.690 |
1 | 5934 | 1.685 |
Price($) | Vol. | No. |
---|---|---|
1.730 | 1574 | 2 |
1.735 | 7747 | 1 |
1.740 | 5664 | 2 |
1.750 | 1800 | 2 |
1.755 | 2678 | 1 |
Last trade - 11.57am 25/06/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |